Meditrina said yesterday that it completed a round of equity financing worth $13 million for the commercialization of its Aveta System for treating intrauterine pathologies. The San Jose, Calif.-based company’s Aveta system won FDA 510(k) clearance in May; the company plans to put the $13 million toward the platform’s market launch. The Aveta system is […]